Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Arcturus Therapeutics Holdings Inc. ARCT

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.


Top institutional share ownership of Arcturus Therapeutics Ltd.

Name Shares Shares % change Value Value % change
Federated Hermes, Inc. 3,561,097 -5.3% $56,052 -44.7%
State Street Corp 2,806,918 -12.8% $44,181 -49.1%
ARK Investment Management LLC 2,303,751 -3.4% $45,799 -28.7%
ARKG - ARK Genomic Revolution ETF 2,268,443 -1.0% $39,811 -10.3%
XBI - SPDR(R) S&P(R) Biotech ETF 2,255,821 -14.8% $35,507 -50.3%
KAUAX - Federated Kaufmann Fund Class A Shares 1,971,300 0.0% $34,596 -9.4%
BlackRock Inc. 1,904,302 12.3% $29,973 -34.4%
FKASX - Federated Kaufmann Small Cap Fund Class A Shares 1,538,297 -20.2% $26,997 -27.7%
Nikko Asset Management Americas, Inc. 1,436,194 2.4% $17,952 -52.6%
Sumitomo Mitsui Trust Holdings, Inc. 1,436,194 2.4% $22,606 -40.2%

Top institutional buyers of Arcturus Therapeutics Ltd.

Name Shares % change Value % change Shares Value
Schonfeld Strategic Advisors LLC 251.7% 105.3% 267,597 $4,212
Point72 Asset Management, L.P. 114.8% 25.4% 913,323 $14,376
Goldman Sachs Group Inc 31.3% -23.3% 370,337 $5,829
BlackRock Inc. 12.3% -34.4% 1,904,302 $29,973
Morgan Stanley 11.5% -34.9% 312,211 $4,913
IWM - iShares Russell 2000 ETF 9.5% -36.1% 526,675 $8,290
Northern Trust Corp 7.8% -37.1% 208,896 $3,288
Geode Capital Management, Llc 5.8% -38.2% 392,537 $6,178
Vanguard Group Inc 3.5% -39.6% 1,193,656 $18,787
Nikko Asset Management Americas, Inc. 2.4% -52.6% 1,436,194 $17,952

Top institutional sellers of Arcturus Therapeutics Ltd.

Name Shares % change Value % change Shares Value
FKASX - Federated Kaufmann Small Cap Fund Class A Shares -20.2% -27.7% 1,538,297 $26,997
XBI - SPDR(R) S&P(R) Biotech ETF -14.8% -50.3% 2,255,821 $35,507
State Street Corp -12.8% -49.1% 2,806,918 $44,181
ACT Capital Management, LLLP -10.5% -47.8% 226,600 $3,567
Federated Hermes, Inc. -5.3% -44.7% 3,561,097 $56,052
ARK Investment Management LLC -3.4% -28.7% 2,303,751 $45,799
ARKG - ARK Genomic Revolution ETF -1.0% -10.3% 2,268,443 $39,811
Jpmorgan Chase & Co 0.0% -41.6% 325,060 $5,116

Information provided by Fintel.io